GE HealthCare Technologies Inc.

GEHC

US36266G1076

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 02:30:00 14/02/2026 am IST			5-day change	1st Jan Change
80.34 ^USD	+2.15%		-0.38%	-2.05%

13/02	GE Healthcare Technologies Inc. Declares Cash Dividend for the First Quarter of 2026, Payable on May 15, 2026	CI
09/02	GE Healthcare Launches ReadyFix Fleet Management Solution to Help Enhance Operational Efficiency and Reliable Patient Care	CI

Goldman Sachs Adjusts Price Target on GE Healthcare Technologies to $98 From $86, Maintains Buy Rating

Published on 01/09/2026 at 08:39 pm IST

MT Newswires

Latest news about GE HealthCare Technologies Inc.

13/02	GE Healthcare Technologies Inc. Declares Cash Dividend for the First Quarter of 2026, Payable on May 15, 2026	CI
09/02	GE Healthcare Launches ReadyFix Fleet Management Solution to Help Enhance Operational Efficiency and Reliable Patient Care	CI
09/02	GE Healthcare launches Readyfix fleet management solution	RE
09/02	GE HealthCare Launches ReadyFix Remote Device Management in US	MT
06/02	Rothschild & Co Redburn Adjusts Price Target on GE Healthcare Technologies to $110 From $108, Maintains Buy Rating	MT
06/02	BNP Paribas Adjusts Price Target on GE Healthcare Technologies to $95 From $92, Maintains Outperform Rating	MT
06/02	GE Healthcare announced a collaboration with Diagnoly to advance the use of artificial intelligence in fetal ultrasound assessments	RE
05/02	Barclays Adjusts Price Target on GE Healthcare Technologies to $87 From $86, Maintains Equalweight Rating	MT
05/02	Evercore ISI Adjusts Price Target on GE Healthcare Technologies to $98 From $95, Maintains Outperform Rating	MT
05/02	Piper Sandler Adjusts Price Target on GE Healthcare Technologies to $96 From $94, Maintains Overweight Rating	MT
05/02	Wells Fargo Adjusts Price Target on GE Healthcare Technologies to $97 From $95, Maintains Overweight Rating	MT
05/02	Goldman Sachs Adjusts GE Healthcare Technologies PT to $97 From $98, Maintains Buy Rating	MT
05/02	Stifel Nicolaus Adjusts GE Healthcare Technologies PT to $98 From $95, Maintains Buy Rating	MT
05/02	BTIG Research Adjusts GE Healthcare Technologies PT to $91 From $87, Maintains Buy Rating	MT
04/02	Tranche Update on GE HealthCare Technologies Inc.'s Equity Buyback Plan announced on April 30, 2025.	CI

Chart GE HealthCare Technologies Inc.

Duration

Period

GEHC: Dynamic Chart

GE HealthCare Technologies Inc. is a medical technology, pharmaceutical diagnostics, and digital solutions company. The Company provides integrated solutions, services, and data analytics. Its segments include Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a comprehensive portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its Ultrasound segment includes ultrasound medical devices and solutions with a portfolio of continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. The segment also includes the clinical artificial intelligence (AI) software business. Its PCS segment portfolio consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment consists of two business lines: contrast media and molecular imaging.

Employees

54,000

Sector

Advanced Medical Equipment & Technology

Calendar

26/02 - Citi MedTech and Life Sciences Access Day

More about the company